Health Care & Life Sciences » Biotechnology | Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.96
Market Cap
$163.85 M
Shares Outstanding
27.49 M
Public Float
23.66 M

Profile

Address
131 Hartwell Avenue
Lexington Massachusetts 02421
United States
Employees -
Website http://www.aldeyra.com
Updated 07/08/2019
Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A.

Financials

View All
Created with Highcharts 5.0.14Aldeyra Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.12 23712 2375 1875 18712 09012 09018 69918 69922 34022 34038 89338 893201320142015201620172018010k20k30k40k50k

Richard H. Douglas
Chairman
Todd C. Brady
President, Chief Executive Officer & Director